Specialty Diagnostix Limited

Specialty Diagnostix Limited is a small, active company based in St Albans, UK, founded twelve years ago in 2012. With £474,068 in assets and a virtual address, it employs just two people and is run by two directors and owners, representing a family business. The company regularly imports miscellaneous chemical products, with its last import operation occurring five months ago in April 2023. It operates within the wholesale of pharmaceutical goods industries.

The company’s website showcases a specialized business focused on laboratory analysis. It offers a range of products and services, including drug abuse testing, therapeutic drug monitoring, and dry blood analysis. It caters to a broad geographical reach, partnering with companies across Europe, Asia, and the Americas. The website highlights a commitment to innovation and quality, emphasizing its use of recombinant glucuronidases and advanced sampling systems. It's a B2B operation, not an e-commerce site, focusing on supplying reagents, calibrators, and controls to laboratories rather than selling directly to consumers.

Financially, Specialty Diagnostix Limited shows a mixed picture. Current assets increased by 40% to £470,000, while net assets grew by 69% to £260,000. Cash reserves surged 38% to £320,000, indicating improved liquidity. Trade debtors increased by 49% to £150,000, potentially reflecting increased sales or extended payment terms. However, creditors also rose by 14% to £210,000, and bank borrowings increased. The company's small size (meeting two of three conditions for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for agility, but the rise in debt warrants attention. The accounts are unaudited, and no auditor is mentioned, which is typical for small companies.

Registered in England/Wales under the registration number 08230058, with a registered address at AL1 1LJ, St Albans, Hertfordshire, Pendragon House, 65 London Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.